Literature DB >> 11505970

Cytokine blockade in rheumatoid arthritis.

M Feldmann1, R N Maini, J Bondeson, P Taylor, B M Foxwell, F M Brennan.   

Abstract

As we enter the 2000's it is clear that cytokine blockade is an effective therapeutic strategy for rheumatoid arthritis. In this brief review, we will review the rationale for anti TNFalpha therapy, the current status of therapy and focus on the regulation of TNFalpha production in rheumatoid synovium. New approaches to studying TNF regulation in RA and of elucidating the controversial role of T cells in this complex disease will be described.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11505970     DOI: 10.1007/978-1-4615-1243-1_13

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  15 in total

1.  Differential effect of Fc gamma receptor ligation on LPS-stimulated TNF-alpha secretion by hepatic, splenic, and peritoneal macrophages.

Authors:  Daniel J Loegering; Michelle R Lennartz
Journal:  Inflammation       Date:  2002-12       Impact factor: 4.092

Review 2.  Prospects for the development of small molecular weight compounds to replace anti-tumour necrosis factor biological agents.

Authors:  B Foxwell; E Andreakos; F Brennan; M Feldmann; C Smith; M Conron
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

3.  Immunosuppressive activity of deer antler extracts of Cervus korean TEMMINCK var. mantchuricus Swinhoe, on type II collagen-induced arthritis.

Authors:  Sung-Koo Kang; Kap-Sung Kim; Sung-Il Kim; Kang-Hyun Chung; In-Seon Lee; Cheorl-Ho Kim
Journal:  In Vitro Cell Dev Biol Anim       Date:  2006 Mar-Apr       Impact factor: 2.416

Review 4.  The three human monocyte subsets: implications for health and disease.

Authors:  Kok Loon Wong; Wei Hseun Yeap; June Jing Yi Tai; Siew Min Ong; Truong Minh Dang; Siew Cheng Wong
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

5.  Angiogenic and Arthritogenic Properties of the Soluble Form of CD13.

Authors:  Yuxuan Du; Chenyang Lu; Rachel L Morgan; William A Stinson; Phillip L Campbell; Ellen Cealey; Wenyi Fu; Nicholas J Lepore; Jonatan L Hervoso; Huadong Cui; Andrew G Urquhart; Jeffrey N Lawton; Kevin C Chung; David A Fox; Mohammad A Amin
Journal:  J Immunol       Date:  2019-06-12       Impact factor: 5.422

6.  Signaling pathways for Fc gamma receptor-stimulated tumor necrosis factor-alpha secretion and respiratory burst in RAW 264.7 macrophages.

Authors:  Daniel J Loegering; Michelle R Lennartz
Journal:  Inflammation       Date:  2004-02       Impact factor: 4.092

7.  Resistance to development of collagen-induced arthritis in C57BL/6 mice is due to a defect in secondary, but not in primary, immune response.

Authors:  Meng Pan; Insoo Kang; Joe Craft; Zhinan Yin
Journal:  J Clin Immunol       Date:  2004-09       Impact factor: 8.317

8.  The effect of blockade of tumor necrosis factor alpha on VLA-1+ T-cells in rheumatoid arthritis patients.

Authors:  Shomron Ben-Horin; Itamar Goldstein; Alexander Koltakov; Pnina Langevitz; Michael Ehrenfeld; Esther Rosenthal; Hanan Gur; Ilan Bank
Journal:  J Clin Immunol       Date:  2007-09-22       Impact factor: 8.317

9.  Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliterans.

Authors:  Ryan Flynn; Jing Du; Rachelle G Veenstra; Dawn K Reichenbach; Angela Panoskaltsis-Mortari; Patricia A Taylor; Gordon J Freeman; Jonathan S Serody; William J Murphy; David H Munn; Stefanie Sarantopoulos; Leo Luznik; Ivan Maillard; John Koreth; Corey Cutler; Robert J Soiffer; Joseph H Antin; Jerome Ritz; Jason A Dubovsky; John C Byrd; Kelli P MacDonald; Geoff R Hill; Bruce R Blazar
Journal:  Blood       Date:  2014-05-12       Impact factor: 22.113

10.  Patient demographics and disease variables correlate with distinct cytokine patterns in mitogen-stimulated peripheral blood mononuclear cells from rheumatoid arthritis patients.

Authors:  Sukhbir Singh Uppal; Raj Raghupathy; Sawsan J Hayat; Rafiqul Islam Chowdhury; Mini Abraham; Parvez Rawoot
Journal:  Rheumatol Int       Date:  2007-11-29       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.